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Early cellular events in the malignant transformation of 
melanocytes to melanoma are virtually unknown. In vitro 
investiga tion of this phenomenon has been hampered by 
the fas tidious nature of the human epidermal melanocyte, 
which has proven diffi cult to cultivate. The present study 
COITlpares responsiveness of cultured human epidermal 
melanocytes and established melanoma cell lines to serum, 
cholera toxin, and melanocyte growth factor (MGF), three 
es ta blished melanocyte mitogens. Four of four established 
hUITlan melanoma lines were substantially stimulated by 
feta l bovine serum, as were newborn foreskin-derived epi-
dermal melanocytes. In contrast, none of the four mela-
nOITla lines responded to hypothalamic prepara tions con-
taining MGF that consistently produced an approximately 
3D-fold increase in newborn melanocyte cell yield over a 
M elanoma h as long been the fo cus of intense clin-ical and laboratory investiga tion because of Its serious prognosis and its pro pensity to affl ict youn ger adults. Both in cidence and death rate for melano m a have been increasin g rapidly over 
the past decades [1 ,2), with a current incidence approximately of 
10,000 cases per year and a lifetime risk of 1 in 250 in the United 
States [3) . 
It is well es tablished that early diagnosis is critical to effective 
managem ent of m elanoma [4) . The recognition of clinical features 
associated with early invas ive lesions [5 ,6) and with specific pre-
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cMGF: crude melanocyte growth f.1Cto r 
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HSM: hormone-supplemented medium 
M-CM: melanoma conditioned medium 
MGF: melanocyte growth factor 
TGF: transforming growth facto r 
2-week period . Cholera toxin, required for successful es-
tablishment of primary melanocyte cultures, had sm all and 
variable effects on the melanoma lines, with slight stim-
ulation in one case, m oderate inhibition in another, and 
essentially no effect in two others . These data suggest that 
transformation of epidermal melanocytes to melanoma often 
involves at leas t one phenotypic change resulting in escape 
from MGF regulation and another associa ted with insen-
sitivity to cyclic AMP modulation; while at leas t some of 
the pathways conferring serum dependence are unaltered. 
Improved culture systems for the human epidermal mel-
anocyte should facilitate further studies into the m echanism 
of its m alignant conversion and may provide useful insights 
for the prevention and treatment of human melanoma. J 
Invest D ermatol 87:723- 727, 1986 
cursor lesions [7) has represented significant public health con-
tributions. Unfo rtunately, technical di fficu lties in culturing mel-
anocytes, the norm al counterpart of melanoma cells, have virtually 
prohibited examination of the ea rly cellular even ts in the process 
of m alignant transformation. O nly recently have melanocytes 
successfully been grown in pure culture, and som e information 
obtained regarding their stringent growth requirem ents [8-12). 
The present report compares the relative responsiveness of human 
melanocytes and es tablished melanoma lines w ith selected mi-
togenic stimuli: fetal bovine seru m (FBS), cho lera toxin (CT), 
and a recently described [13] melanocyte growth-promo ting ac-
tivity present in bovine h ypothalamic extracts, term ed melano-
cyte growth factor (MGF) . 
MATERIALS AND METHODS 
Cell Lines Four es tablished human melanoma cell lines were 
used: CRL 1424 [14) and CRL 1619 [15) were purchased from 
the American Tissue C ulture Collection ; TANG [1 6] and NEL 
[17) w ere generously provided by Drs. David Parkinson and 
D ennis DiSorbo, respectively. For simplicity, the four melanoma 
lines are referred to in the text as line 1 (CRL 1424), line 2 (TAN G), 
line 3 (NEL) , and line 4 (CRL 1619). Normal human epidermal 
m elanocytes were cultivated from newborn foreskins using es-
tablished techniques under conditions previously confirmed by 
electron microscopic criteria to yield pure melanocyte cultures 
through at least 3-4 passages [10) . 
Cell Culture The melanoma lines were maintained in 100-mm 
dishes (Falcon, Becton Dickinson, Oxnard, California) in Dul-
becco's modified Eagle's medium (DMEM, Gibco, Grand Island, 
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N ew York) supplemented w ith 10% FBS (MA Bioproducts, 
Walkersfield , Maryland) and seri all y passaged at a 1 : 10 split ratio 
w ithin 24 h of achiev ing confluence . Melanocytes were main-
tained in a ho rm one-supplemented medium (H SM) consistin g of 
M1 99 (Gibco) with 10 ng/ml epidermal grow th facto r (Collab-
orative Resea rch, Lexing ton, M assachusetts), 10 J.Lg/ml insulin 
(S igm a, St. Loui s, Missouri) , 1 O - ~ M trii odo th yronine (Sigma), 
10 J.Lg/ml transferrin (Sigm a), 1.4 X 10 - (' M hydrocortisone (Ca l-
biochem-Behrin g, San Diego, C alifo rni a), 10 - ~ M C T (C albi-
ochem-Behring), and 100 J.Lg/ml bovine hypo th alamic ex tract 
prepared as previ ously described 113] and kn own to contain MG F. 
Fo r growth ex periments 2 x 10" m elano ma cell s or 4 X 10" 
m elanocytes w ere inoculated into 35-mm dishes (Falcon) con-
taining 2 ml of HSM and variable concentrations o f FBS, CT , 
and the crude extract containing M GF (cM G F) . Fresh medium 
was provided to melanoma cultures once on day 3 or 4, and to 
melanocy te cultures 3 times a w eek. M elano ma ex periments were 
termin ated on day 7 and melanocyte experim ents on day 14 to 
accommodate the different cell g rowth rates . All cultures were 
routinel y m onito red und er plnse- contras t mi croscopy. To ex-
clude the poss ibility o f fib ro blast contamination of melanocyte 
cultures maintained 14 da ys in hi gh FBS concentration, aliquo ts 
of the cells w ere subsequentl y passaged into both serum-free HSM 
and DME M containing 10% FBS, a medium permittin g rapid 
fi b roblas t proliferati on but insuffi cient fo r melanocyte survi va l. 
Resto ration o f characteristi c dendriti c morph ology in the serum-
free H SM and fa ilure o f cells to proliferate in DME M containing 
10% FBS w as accepted as proof o f melanocytic identity. U sing 
these criteria, no fibro blas t overg rowth was detected. 
M elanom a q mditioned medium (M-CM) w as prepared by in-
cubatin g subconfluent cultures in HSM lackin g bo th cM G F and 
FBS fo r 48 h . The M-C M was then rem oved, frozen immediately , 
concentrated by lyophiliza ti on, and reconstituted in HSM la ckin g 
FBS and cMGF. The reconstituted M-C M w as passed through a 
0.2-J.Lm cellulose acetate filter (Co rnin g Glass, Cornin g, N ew 
York) , and substituted fo r HSM at 2-20% (v : v) at each feeding. 
Experimental Design CeUs fro m sing le o r pooled parent cul-
tures w ere trypsinized , counted, and inocul ated into paired du-
plica te o r tripli ca te dishes at each concentration of the va ri able 
fac tors (FBS, CT, o r cM G F). At termin ation, the ceLIs were de-
tached from each culture dish w ith 1 ml o f 0 .25% trypsin (Gibco), 
vigo ro usly pipetted to form a ho mogenous suspension, and du-
plicate to quadruplica te counts perform ed either in a hemocy-
to meter (melano ma cells) o r a Coulter counter m odel ZM (m el-
anocy tes). Differen ces in cell number w ere tested for statisti cal 
signifi cance using analysis o f variance. 
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RES ULT S 
Morphology N ormal newborn melanocytes maintained in HSM 
se rum frcc o r with 2% se rum cx hibitcd primarily bipolar to tri-
po lar m orphology and tcndcd to co ntact each other primaril y via 
dcndritic projecti ons cvcn at moderately hi gh cell density , as pre-
viously dcscribcd [10] . In contras t , all 4 o f the melanoma lines 
grown under the same conditions w ere chara cterized by small, 
round to polygonal cells, which werc arran ged in tight clusters 
cven at low density (Fig 1) . Melanocytes g rown in the presence 
o f 5-20% FBS show ed an in creasing ly bipo lar and hence fibro-
blas t-like appca rance, while in contras t incrcased FBS concentra-
tion had no effect on the appca rance o f melanoma cells . Removal 
of thc C T from th e medium for 14 days had little effect on the 
morpho logy o f the melanocytes, and addition of CT had no effect 
on any of th e melanom a lines . Removal of cMGF caused mela-
nocytes to appea r vacuolated within 10 days; no morphologic ef-
fect was o bserved when melano m a cells w ere deprived of cMGF. 
Response to Mitogens As anticipated , bo th melanocytes and 
mclanoma showcd a substanti al pos itivc response to FBS (Figs 
2, 3). Thc increasin g cell yields obtained in 5-20% FBS reflect 
different grow th rates rather than different confluent densities 
beca use at the time of harves t all cultures were cl earl y subcon-
flu cnt as determined by phase-microscopic cxamination; and in 
separatc expcriments with melano ma cell counts at days 1, 3, 7, 
10, and 14, Iinca r growth was found to continue to approximately 
tw icc thc o ri ginal day 7 cell densitics fo r each FBS concentration . 
T he m agnitude of res ponse to FBS va ried m arkedl y among do-
no rs in the casc o f m elanocy tes and w ith the deg ree of confluence 
and imm ed iatc pas t g rowth statu s o f the parent culture fo r the 
m clanom a lines, but thc responsc w as always significant with 
max imal stimulati on at cithcr 10 o r 20% FBS. 
In contras t, the responscs of melano m a cell s and melanocy tes 
to CT werc divergent. Melanoma Iincs "] and 4 w ere unaffected 
by CT , w hile Iinc 3 w as sli ghtly to moderatel y inhibited and line 
2 w as sli ghtl y stimulated (Fig 2). An alogous experiments with 
m clanocy tes wcre not perfo rm ed, as attempts to initiate mela-
nocyte culturcs in the absence o f C T yielded too few cells; 
w ithdraw al o f C T from th e m edium 3 da ys after plating resulted 
3-4 wccks later in melanocytes that passaged very poorly and 
wcre unresponsive to FBS o r cM GF as secondary cultures. Be-
ca use C T cova lentl y m odifi es a rcgulato ry component of aden-
ylate cyclasc, its effects are vcry long las ting [1 8], and periods of 
withdrawal sho rter than 3- 4 w eeks were considered insufficient 
to eliminate its influcnce. 
Thc effect of cM GF on melanoma cell s was first examined in 
Figure 1. Cultured human epiderm al melanocy tes and melanoma cells. n, Primary culture of melanocytes deri ved from newborn foreskin, 18 days 
after initiation. The cells do not form colonies, and tend to remain separate from each other even at hi gh density. Note large cell size and hi ghly 
variable morphology , rangin g from stellate to bipolar. Granular appea rance of the cytoplasm is particularl y marked in cultures derived from black 
donors, as in this instance. b, Melanoma line 4. These ce lls form tight colonies, are small, uniform in appearance, and do not form dendrites. The 
other 3 melanoma lines exhibited similar characteristi cs . Phase contract micrographs, 300 x original magnifica tion. 
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Figure 3. Growth response of epidermal melanocytes to FBS. Vertical 
ax is is cell number "10 - 4 • Plotted va lues are the mean and SEM (bars) of 
one representative experiment. FBS significantly increased cell yield (p < 
0.001). There was considerable variability in absolute cell yield among 
individual donors, but comparable serum effects were always noted. 
To investiga te the possibility that melanoma cells escape MGF 
dependence via an autocrine mechanism , conditioned m edium 
obtained from each of the m elanomas was added to melanocy te 
cultures. Addition of 2-20% M-CM to mel anocyte cultures in-
ocu lated in HSM containin g 2% FBS and lacking cMGF fai led 
to stimulate melanocyte g rowth above th at of the cMGF- deprived 
controls. No further experiments were undertaken to explore the 
possibility of autocrine stimulation of these melanoma lines by 
an MGF-like substance. 
" 
'0 
_0 
Figure 2. Growth response of melanoma cell lines to FBS in the presence 
(open s ymbols and dotted lilies) and absence (closed sYlllbols and solid lili es) of 
CT 10- 9 M . Vertical axis is cell number times "10 - 4 Melanoma cells 
maintained in DMEM with 10% FBS were passaged into paired dishes 
containing HSM supplemented with 100 fLg/ml cMGF and the indicated 10 
concentrations of FBS and CT. FBS significantly stimulated growth for ~ 
all 4 lines (p < 0.001). Lines 1 and 4 were unaffected by CT, while line ~ 
2 was slightly stimulated and line 3 was inhibited (p < 0.05). There was ~ 
no evidence of interaction between CT and FBS. Plotted values are the ~ 
mean of representative experiments performed in duplicate. Standard er- i 
rors are < 10% of the mean for all points. 
2' .0 100 .. .0 100 
the absence of CT and in the presence of 2% FBS, conditions 
that consistently produced less than half-maximal growth for all 
fo Ul: melanoma lines. No melanoma line showed stim ulation of 
gro"Wth at any concentration of cMGF (Fig 4). Repeat experimen ts 
perform ed in the presence of 10- 9 M CT gave identical results, 
w ith a ll cell yields at each cMGF concentration falling within 20% 
of those obtained in the absence of CT. Overall differences in 
perce nt stimulation by cMGF observed in th e presence vs the 
absen ce of CT w ere 2, 3, 10, and 18%, with no statistically 
significant differen ces between any of the four paired melanoma 
cell lines. In creasing the FBS concentration to 5% also failed to 
produce any response to cMGF. In contrast, as previously re-
ported [10,13]. cMGF was highly stimu latory to melanocytes 
under very similar culture conditions (Fig 4) . 
a b cMGF lug/a ll 
Figure 4. Response of epidermal melan'ocytes and melanoma lines to 
cMGF. Vertical axis is cell number 10 - 4 . All cultures were maintained 
in the HSM containing 2% FBS and the indicated concentrations of cMGF. 
Melanocyte cultures (a) contained 10 - 9 M CT; melanoma cultures (b) did 
not. Plotted va lues are the mean and SEM from duplicate dishes of rep-
resentative experiments. Melanocytcs were markedly stimulated by cMGF 
(p < 0.001) , while nonc of thc melanoma lines showed any effect of 
cMGF on cell yield. [Linc 1, circle; line 2, dialllolld; line 3, triallgle; and line 
4, square. ] 
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DISCUSSION 
Examination of altered g rowth regulatio n of melanoma cells is 
hampered by our severely limited knowledge of growth require-
ments for the normal melanocyte. Thus far, data have been re-
ported regarding only four g rowth-promoting activiti es for hu-
man. me]anocytes in vitro: serum [1 0, 13]. CT and other agents 
that 1I1crease cAMP levels [9,13,1 9,20], phorbol esters [9,21), and 
the melanocyte g rowth factor, a 30,000 dal ton substance extracted 
from bovine hypothalamus [10,13]. G rowth-stimula ting activities 
for human melanocytes have been described in various condi-
tioned media and cell extracts, but the factors have yet to be 
characterized [21-24) . Melanocyte-stimulatin g hormone, one of 
the few purported physiologic regulators of melanogenesis and 
possibly proliferation in vivo [25]. has to date proved inactive for 
human melanocytes in available culture systems [S,26,27J. N erve 
g rowth factor, a theoretic ca ndidate, is also inactive [1 3; Gordon, 
Murph y, and Gilchrest, unpublished observatio ns). Ultraviolet 
irra~ i atio n, associa ted with both melanogenes is and melanocyte 
prol~feratlon 111 VIVO [2S). has been utilized in only one published 
111 vitro stud y fSJ in which th e irrad iation protocol resulted in a 
substantial decrease in human melanocy te number. 
The present study exa mines the effect of 3 of the above-
described epidermal melanocyte growth stimulators on the growth 
of its transformed counterpart, the melanoma cel l. Phorbol esters 
were not examined because their known tumor-promoting ca-
paCIty [29) might blur distin ctions between the normal cells and 
the tumor cells and because phorbol esters do not promote growth 
of normal melanocy tes in o ur culture system [30). 
All 4 established melanoma lines were found to be stimulated 
by FBS, as were normal melanocytes. Serum is known to provide 
a Wide array of attachment factors , nutrients, and mitogens for 
cultured cell s. Therefore, persistent serum responsiveness of the 
four melano m a lines was ex pected, and served in this work as a 
positive control for th e experim ents invo lving MGF and CT. 
None of the melanoma lines displayed the strong growth-
promot1l1g res ponse to CT observed for no rm al epidermal mela-
nocytes, and all were routinely cultivated in its absence. In con-
trast, to date all successful cultivation system s for the normal 
epidermal melanocyte include CT [S, 11 ,13,23]. In the only study 
quantlfy1l1g Its Impact, prolonged removal of CT from the me-
dium reduced melanocyte growth by approximately 50% [13) . 
These observatIOns suggest that transform ation either reduces the 
growth-stimulatory impact of cyclic AMP or results in chroni-
cally elevated levels that are not further modulated by addition 
of CT, altho ugh CT may influence cells independent of the cyclic 
AMP pathway as well [31J . 
In the ho rmone-supplem ented culture system developed in our 
labora to ry, no rmal melanocytes require M GF for proliferation 
and maintenance of normal morphology [1 0, 13). In contrast, all 
4 mel~noma lines failed to res pond to this fac to r. MGF is a recently 
desCribed ac ti vity 111 extracts prepared from human or bovine 
hypothalam us that exhibits heat and alkaline lability and partial 
aCid labilIty. It IS weakly bas ic, and has an approximate molecular 
weight of 30,000 (1 3). Purification efforts to date are consistent 
with the prese~ce of a single substance, presumably a protein. 
POSSible bio logic or therapeutic roles for this potent in vitro mi-
togen remain to be determined. 
Transformed cells are well known to exhibit redu ced depen-
dence on growth factors, and at least three classes of alterations 
have been delineated [32,33). First, transformation may be ex-
pressed at the membrane level by production of an altered receptor 
that transmits signal 111 the absence ofligand [34-36). N o evidence 
presen tl y supports this mechanism for melanoma. Second the 
cytosolic signal for proliferation may be tonically elevated. ' The 
ras gene product, a cytosolic guanosine-binding pro tein , has been 
proposed ~o act in this way [32], an d altered ras oncogenes have 
been. Identified 111 severa l melano ma lines [37-40). although their 
rel atIOns hip to transformation is qu estionable [37] . Third, some 
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tr~n s formerl cells are known to esca pe regulation through auto-
cr1l1e productio n of growth fac tors no rmall y available onl y from 
extracellular sources (41) . This mechanism at present is the best 
documented with regard to melano ma. A human melanoma was 
among the first tumors recognized to secrete transforming growth 
factors (TGFs) f 42]. a class of proteins ca pable o f stimul ating 
grow th and reversibly conferring a transformed phenotype on 
normal cells [33) ; TGF was first isolated and characterized from 
a human melanoma line [43 ,44). and recently the first purification 
of TGF from a human source in vivo was achieved using urine 
obtained fro m a patient with metastatic melanoma [45] . Other 
work has questioned , but not eliminated , a role for T G F in the 
autocrine growth stimulation of melanoma cells [24,46]. The hu-
man melanoma line Hs0294 has been reported to secrete an un-
charac terized growth-promotin g act ivity th at stimulates both 
melano ma and nevus cells [24] ; extracts of human melano ma cells 
have recentl y been reported to increase the yield of newborn 
melanocytes under certain cultu re conditions, although medium 
conditioned by the sa me cells was not stimulatory (21) . In the 
present study, attempts to demonstrate secretion of an MGF-like 
activity from 4 MGF refractory melanoma lines failed to provide 
evidence supporting an autocrine mechanism o f g rowth factor 
independen ce. H owever, this remains an attractive possibility, 
especially in light o f recent work suggestin g that a growth-pro-
motin g activity for human hepatocy tes, first identified in brain 
extracts [47] , is responsible for autocrine growth stimulation of 
cultured human hepatoma lines [4S). 
Alth ough melano ma lines have long been cu ltured with little 
difficulty [49, 50], human melanocy tes have only recently been 
grown successfully in culture [S-10]. presumably due to their 
veryslow g ro w th rate, low number in skin , and stringent growth 
requirements. ThiS study demonstrates that melanomas, like other 
cancers, have reduced growth fac tor regul ation relative to the 
1l00~transformed cell of origin, and suggests that quantitative com-
parisons are now feasible . 
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